上海萊士(002252.SZ):控股股東質押股票違約 已被動減持3679萬股
格隆匯3月20日丨上海萊士(002252.SZ)公佈,公司控股股東科瑞天誠投資控股有限公司(“科瑞天誠”)原質押給中信證券的8805萬股上海萊士股票因逾期並低於平倉線構成違約。鑑於前述情況,中信證券以向法院申請強制執行方式對質押的標的證券進行違約處置,並於2020年1月2日至2020年3月6日期間通過集中競價交易方式減持3679萬股上海萊士股票,科瑞天誠因此被動減持上海萊士股份3679萬股,占上海萊士總股本的0.74%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.